Evaluation of Short-term Outcomes of Ambulatory Loop Ileostomy Reversal

West China Hospital216 enrolled

Overview

Based on enhanced recovery after surgery (ERAS), ambulatory loop ileostomy reversal (ALIR) has been reported in developed countries. However, there is still no research proposing how to carry out ALIR in developing countries. This study was performed to determine the feasibility of ALIR in China based on the community hospital joined enhanced recovery after surgery (CHJ-ERAS) program.

CHJ-ERAS program for ALIR was launched. Patients who underwent loop ileostomy with age ≤ 65 and ASA II or III were enrolled and underwent ALIR after rigorous evaluation. Strict follow-ups were conducted after ALIR. The primary outcome was the results of short-term follow-ups.

Study Type

OBSERVATIONAL

Enrollment

216

Conditions

Surgery Fast Recovery Surgery

Interventions

day-case surgeryOTHER

Patients who underwent loop ileostomy with age ≤ 65 and ASA II or III were enrolled and underwent ALIR after rigorous evaluation.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with ileostoma and preparing for LIR 2. Patients age between 18-65; 3. ASA grade II; 4. Patients willing to underwent day-case LIR Exclusion Criteria: * 1\) Patients who underwent single-lumen ileostomy, transverse colostomy or Hartmann; 2) Complex previous laparotomies or required exploratory laparotomy; 3) Age over 65; 4) ASA grade over III (assessed by anesthetists); 5) Presence of moderate or severe preoperative anemia (hemoglobin \<90g/L); 6) Therapeutic anticoagulation or anti-platelet medications used within 1 week before surgery; 7) Patient refusal; 8) Severe co-morbidities or other conditions evaluated by surgeons or anesthetists not inappropriate to be included in the program.

Locations (1)

West China Hospital

Chengdu, Sichuan, China

RECRUITING

Outcomes

Primary Outcomes

Results of short-term follow-up

The occurrence of postoperative complications

Time frame: Within 1 month after surgery

Readmissions

Readmission within 1 month after surgery

Time frame: Within 1 month after surgery

Reoperation

Reoperation within 1 month after surgery

Time frame: Within 1 month after surgery

Secondary Outcomes

Hospital stays

Time frame: 1 day

Central Contacts

Ziqiang Wang, PHD

CONTACT

+8618980602028 wangziqiang@scu.edu.cn

Yu Shen, MD

CONTACT

+8617606441760 hi_moke@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.